Bucindolol

DB12752InvestigationalSmall molecule

Bucindolol has been investigated in Heart Failure.

Mechanism: Pharmacologically active on Beta-1 adrenergic receptor, Alpha-1 adrenergic receptors, and Beta-2 adrenergic receptor
Curator reviewed
Formula / weight: C₂₂H₂₅N₃O₂ · 363.461 g/mol (avg)

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyFBMYKMYQHCBIGU-UHFFFAOYSA-NSMILESCC(C)(CC1=CNC2=CC=CC=C12)NCC(O)COC1=CC=CC=C1C#N

Targets

What you can answer from here — as of August 31, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1,130Drug interactionsStructured to mechanism, not free text

2Clinical trialsPhase, status and sponsor resolved per trial

11+ReferencesStructured and connected to the statements they support

Which drugs share a target with Bucindolol, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.